Skip to main content
logo
CANbridge Pharmaceuticals Inc. (HKG:1228)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
1.990
0.00 (0.00%)
Jul 31, 2026, 4:08 PM HKT

CANbridge Pharmaceuticals Ratios and Metrics

Millions HKD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
1,1851,308574201,0403,767
Market Cap Growth
184.61%2215.73%-86.56%-59.57%-72.40%-
Enterprise Value
1,1291,3451692785156,284
Last Close Price
1.992.560.130.992.458.88

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
59.6179.35----
PS Ratio
21.3023.520.623.7111.6498.48
PB Ratio
-3.12-3.44-0.11-9.592.984.43
P/TBV Ratio
----3.544.78

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
20.2924.181.862.455.76164.28

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
-0.05-0.05-0.29-3.570.500.08
Net Debt / Equity Ratio
0.150.15-0.26-0.11-1.00-1.00
Net Debt / EBITDA Ratio
0.620.62-0.38-0.010.691.07
Net Debt / FCF Ratio
1.321.32-1.02-0.021.041.17
Asset Turnover
0.350.350.330.190.100.04
Inventory Turnover
0.890.893.694.162.591.77
Quick Ratio
0.200.200.080.541.734.17
Current Ratio
0.240.240.090.641.824.37
Return on Equity (ROE)
----281.91%-96.51%-
Return on Assets (ROA)
-40.72%-40.72%-83.10%-41.75%-35.90%-55.38%
Return on Capital Employed (ROCE)
31.70%31.70%93.10%-543.70%-108.00%-92.70%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
1.39%1.26%-833.62%-99.30%-52.58%-35.10%
FCF Yield
-3.59%-3.25%-230.71%-74.27%-32.21%-19.30%
Buyback Yield / Dilution
-7.60%-7.60%-0.11%-0.04%-350.13%-37.39%